Financials
Financial year 2025
Société scientifique de médecine générale d'Expression française from Sint-Gillis (bij-Brussel), company number BE0410639602, closed financial year 2025 with a result of € 199,185 after tax. For that financial year Société scientifique de médecine générale d'Expression française recorded a gross margin of € 893,465 and equity of € 3.1 million. Compared with financial year 2024, the result moved from € 20,810 to € 199,185. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 6, 2026.
€ 3.1 million
▲ 7% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 199,185
▲ € 178,375 vs 2024
Profit after tax over the fiscal year.
€ 875,425
▲ 40% vs 2024
Cash and bank balances on the last day of the fiscal year.
People and assets in 2025
9.7
▲ 0.4 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 640,055
▼ 9% vs 2024
€ 66,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 129,727
▲ 15% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 70,079
▲ 43% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 165,806
▲ 10% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 1,090,564 | € 952,659 | € 808,327 | € 893,465 | ▲ 11% |
| Profit after taxes | € 374,118 | € 130,997 | € 20,810 | € 199,185 | ▲ € 178,375 |
| Equity | € 2,760,939 | € 2,891,936 | € 2,912,746 | € 3,111,931 | ▲ 7% |
| Total debts | € 688,333 | € 588,203 | € 453,066 | € 546,674 | ▲ 21% |
| Cash | € 723,304 | € 738,437 | € 625,745 | € 875,425 | ▲ 40% |
| Land & buildings | € 123,154 | € 112,445 | € 101,736 | € 91,027 | ▼ 11% |
| Retained profit | € 1,369,365 | € 1,500,362 | € 1,521,171 | € 1,720,356 | ▲ 13% |
| Balance sheet total | € 3,449,273 | € 3,480,139 | € 3,365,812 | € 3,658,605 | ▲ 9% |
| Employees (FTE) | 8.4 | 9.1 | 9.3 | 9.7 | ▲ 0.4 |
Key figures of Société scientifique de médecine générale d'Expression française, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Société scientifique de médecine générale d'Expression française?
What happened at Société scientifique de médecine générale d'Expression française in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Jean-Philippe AGELAS stepped down as director. NBB
- Alberto PARADA stepped down as director. NBB
- GILLES COLEMONTS stepped down as director. NBB
- CATHERINE LIETAER stepped down as director. NBB
- GUY BEUKEN stepped down as director. NBB
- MARTHE KNOPS stepped down as director. NBB
- SOPHIE KUTZNER stepped down as director. NBB
- VIRGINIE DE RIDDER stepped down as director. NBB
In short
From € 374,118 profit in 2022 to € 199,185 profit in 2025.
Paid € 95 in corporate taxes since 2022.
Best year ever: 2022, with € 374,118 profit.
On average € 92,100 of value added per employee in 2025.
Management
Directors
According to the 2025 annual accounts
Sarah CUMPS
Director
since 2024 · until 2028
Jean-Philippe AGELAS
Director
since 2025 · until 2029
Alberto PARADA
Director
Also active at: ASSOCIATION DES GENERALISTES DE L'EST FRANCOPHONE DE LA BELGIQUE, Société Médicale Dr PARADA
since 2025 · until 2029
since 2023 · until 2027
GILLES COLEMONTS
Director
since 2025 · until 2029
Imane HAFID
Director
since 2024 · until 2028
CATHERINE LIETAER
Director
since 2025 · until 2029
GUY BEUKEN
Director
Also active at: CENTRE DE COORDINATION FRANCOPHONE POUR LA FORMATION EN MEDECINE GENERALE
since 2025 · until 2029
since 2025 · until 2029
SOPHIE KUTZNER
Director
since 2025 · until 2029
SEBAHAT DERSAN
Director
since 2023 · until 2027
VIRGINIE DE RIDDER
Director
since 2025 · until 2029
Thomas JACOB
Director
since 2023 · until 2027
SONIA GOUDJIL
Director
since 2023 · until 2027
Jean-Marie LEDOUX
Director
since 2023 · until 2027
HANNA BALLOUT
Director
since 2025 · until 2029
AURORE GIRARD
Director
since 2025 · until 2029
Establishments
Establishment units
Physical locations of this company
Zwitserlandstraat 8
1060 Sint-Gillis (bij-Brussel)
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0410.639.602
- VAT number
- BE 0410.639.602
- Registered office
- Zwitserlandstraat 8, 1060 Sint-Gillis (bij-Brussel)
- Names & denominations
- Société scientifique de médecine générale d'Expression française · SSMG
- Enterprise type
- Rechtspersoon
- Legal form
- Non-profit association
- Legal situation
- Normale toestand
- Start date
- 31 October 1968
- Peppol
- Active · Active since 27 Mar 2025
- Activities · NACE
Activiteiten van beroepsorganisaties
Uitgeven van kranten
Uitgeverijen van kranten
Mediarepresentatie
Overige posterijen en koeriers
Uitgeven van tijdschriften
Uitgeven van boeken
Uitgeverijen van tijdschriften
+3